Neurosense Therapeutics Ltd (NRSN)

03:28 AM

NeuroSense trades close to 90 cents as next $1 Nasdaq threshold comes into view - Bez Kabli

03:28 AM

May 25, 2026

Amyotrophic Lateral Sclerosis (ALS) Market Set for Significant - openPR.com

May 25, 2026

May 21, 2026

NeuroSense Therapeutics (NRSN) Slides 4.56% as Support Levels Are TestedExpert Market Insights - Newser

May 21, 2026

May 15, 2026

TradingKey - TradingKey

May 15, 2026

May 11, 2026

NRSN (NeuroSense Therapeutics) Q2 loss narrows 6.9% more than expected, but investors await pipeline catalyst update.Expert Verified Trades - newser.com

May 11, 2026

Apr 29, 2026

NeuroSense Secures Insider-Led $600,000 PIPE at Premium Share Price - The Globe and Mail

Apr 29, 2026

Apr 28, 2026

NeuroSense Announces Pricing of Insider-Led PIPE Financing - The Malaysian Reserve

Apr 28, 2026

Apr 28, 2026

NeuroSense (Nasdaq: NRSN) insiders lead $600K PIPE financing at premium - Stock Titan

Apr 28, 2026

Apr 27, 2026

NeuroSense Therapeutics Ltd. announced that it expects to receive $0.6 million in funding - marketscreener.com

Apr 27, 2026

Apr 27, 2026

Roth MKM Maintains NeuroSense Therapeutics(NRSN.US) With Buy Rating, Maintains Target Price $3 - Moomoo

Apr 27, 2026

Apr 25, 2026

NeuroSense Therapeutics Transitions Chief Medical Officer to Advisory Role Ahead of Key PrimeC Milestones - The Globe and Mail

Apr 25, 2026

Apr 24, 2026

NeuroSense (NRSN) CMO steps down but stays on as advisor for PrimeC - Stock Titan

Apr 24, 2026

Apr 18, 2026

Niva Russek Blum Net Worth (2026) - GuruFocus

Apr 18, 2026

Apr 17, 2026

Ferenc Tracik Net Worth (2026) - GuruFocus

Apr 17, 2026

Apr 17, 2026

Hagit Binder Net Worth (2026) - GuruFocus

Apr 17, 2026

Apr 17, 2026

Alon Ben Noon Net Worth (2026) - GuruFocus

Apr 17, 2026

Apr 17, 2026

Revital Mandil Levin Net Worth (2026) - GuruFocus

Apr 17, 2026

Apr 17, 2026

Tangible book value per share of NeuroSense Therapeutics Ltd. – NASDAQ:NRSNW - TradingView

Apr 17, 2026

Apr 17, 2026

EBIT per share of NeuroSense Therapeutics Ltd. – NASDAQ:NRSNW - TradingView

Apr 17, 2026

Apr 17, 2026

Operating cash flow per share of NeuroSense Therapeutics Ltd. – NASDAQ:NRSNW - TradingView

Apr 17, 2026

Apr 17, 2026

NEUROSENSE THERAPEUTICS LTD (NRSN) Earnings History & Surprises - ChartMill

Apr 17, 2026

Apr 13, 2026

Form 20-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)] - ADVFN

Apr 13, 2026

Apr 13, 2026

Sentiment Review: Is NeuroSense Therapeutics Ltd Equity Warrant benefiting from interest rate changesPortfolio Gains Summary & Community Verified Swing Trade Signals - baoquankhu1.vn

Apr 13, 2026

Apr 12, 2026

Nasdaq Moves: Is NeuroSense Therapeutics Ltd Equity Warrant showing insider buyingPortfolio Value Report & Real-Time Sentiment Analysis - baoquankhu1.vn

Apr 12, 2026

Apr 12, 2026

Patterns Watch: Is NeuroSense Therapeutics Ltd Equity Warrant part of any ETF2026 Top Decliners & Real-Time Price Movement Reports - baoquankhu1.vn

Apr 12, 2026

Apr 10, 2026

If You Invested $1,000 in Neurosense Therapeutics Ltd (NRSN) - Stock Titan

Apr 10, 2026

Apr 09, 2026

Trend Report: Is NeuroSense Therapeutics Ltd Equity Warrant showing insider buyingWeekly Risk Report & AI Powered Buy/Sell Recommendations - baoquankhu1.vn

Apr 09, 2026

Apr 09, 2026

Bank Watch: Is NeuroSense Therapeutics Ltd Equity Warrant showing insider buyingMarket Weekly Review & Daily Stock Trend Reports - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

Chipmakers Recap: Why is NeuroSense Therapeutics Ltd stock going downEarnings Growth Summary & Weekly Market Pulse Alerts - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

Aug Highlights: What are NeuroSense Therapeutics Ltd Equity Warrants earnings expectations2026 Earnings Surprises & Low Risk Entry Point Tips - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

NRSN Analyst Rating Update: D. Boral Capital Maintains 'Buy' Rat - GuruFocus

Apr 08, 2026

Apr 08, 2026

Inflation Data: Is NeuroSense Therapeutics Ltd Equity Warrant stock undervalued right nowEarnings Summary Report & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

Volatility Watch: Can NeuroSense Therapeutics Ltd Equity Warrant keep up with sector leaders2026 Price Momentum & AI Powered Buy/Sell Recommendations - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

Breakout Watch: Is NeuroSense Therapeutics Ltd gaining market share2026 Review & Consistent Profit Focused Trading Strategies - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026

Income Plays: Is NeuroSense Therapeutics Ltd stock a value trap2026 AllTime Highs & Short-Term Trading Opportunity Alerts - baoquankhu1.vn

Apr 07, 2026

Apr 07, 2026

Is NeuroSense Therapeutics Ltd stock a buy or sellMarket Trend Report & Weekly Consistent Profit Watchlists - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026

NeuroSense granted Brazilian patent covering PrimeC composition - TipRanks

Apr 06, 2026

Apr 06, 2026

NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements - marketscreener.com

Apr 06, 2026

Apr 06, 2026

NeuroSense Wins Long-Term Brazilian Patent Protection for ALS Drug PrimeC - TipRanks

Apr 06, 2026

Apr 06, 2026

NeuroSense Granted Brazilian Patent Covering PrimeC Composition - Bitget

Apr 06, 2026

Apr 06, 2026

Form 6-KReport of foreign issuer [Rules 13a-16 and 15d-16] - ADVFN

Apr 06, 2026

Apr 06, 2026

Brazil grants NeuroSense (NRSN) patent protecting PrimeC ALS and Alzheimer’s drug - Stock Titan

Apr 06, 2026

Apr 04, 2026

NeuroSense Therapeutics Faces Nasdaq Deficiency Notices but Retains Listing Status - The Globe and Mail

Apr 04, 2026

Apr 04, 2026

NRSN PE Ratio & Valuation, Is NRSN Overvalued - Intellectia AI

Apr 04, 2026

Apr 04, 2026

NeuroSense Therapeutics Ltd. (NRSN) stock price, news, quote and history - Yahoo Finance UK

Apr 04, 2026

Apr 03, 2026

NeuroSense Therapeutics Receives Nasdaq Notifications on Compliance Issues - National Today

Apr 03, 2026

Apr 03, 2026

NeuroSense Faces Nasdaq Compliance Warning - Intellectia AI

Apr 03, 2026

Apr 03, 2026

Nasdaq flags NeuroSense (NRSN) for bid price and $35M value shortfall - Stock Titan

Apr 03, 2026

Apr 03, 2026

NeuroSense Therapeutics Ltd. Stock Forecast Summary - Meyka

Apr 03, 2026

Apr 03, 2026

NeuroSense (NRSN) Stock: Slides After Nasdaq Compliance Warning on Price and Valuation - parameter.io

Apr 03, 2026

Apr 02, 2026

NRSN’s $1.00 Bid Price Requirement Serves as Key Trigger for Meeting Compliance and Raising Capital - Bitget

Apr 02, 2026